The Company is developing a pipeline of product candidates that leverages the antimicrobial properties of cannabinoids with the BTX 1801 Phase 2a study for the prevention of surgical site infections completed and awaiting data.
Must have been lined up for a while based on the company notes. He’s a great speaker so hopefully we see some traction on sp, horribly undervalued atm
- Forums
- ASX - By Stock
- BOT
- BOT - Anything but charting
BOT - Anything but charting, page-2123
-
- There are more pages in this discussion • 7,221 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M |
Open | High | Low | Value | Volume |
37.0¢ | 37.5¢ | 36.0¢ | $3.051M | 8.277M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 465836 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 301865 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 387357 | 0.370 |
3 | 241000 | 0.365 |
15 | 373586 | 0.360 |
5 | 218767 | 0.355 |
15 | 139007 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 201865 | 2 |
0.380 | 349392 | 5 |
0.385 | 280300 | 3 |
0.390 | 451134 | 6 |
0.395 | 319001 | 3 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |